22.49% | % of Shares Held by All Insider |
72.68% | % of Shares Held by Institutions |
93.77% | % of Float Held by Institutions |
356 | Number of Institutions Holding Shares |
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
SB Investment Advisers (UK) LTD | 73,031,667 | Mar 31, 2024 | 9.89% | 705,924,119 |
Viking Global Investors, L.P. | 69,368,961 | Mar 31, 2024 | 9.39% | 670,520,402 |
QVT Financial LP | 66,719,779 | Mar 31, 2024 | 9.03% | 644,913,408 |
Blackrock Inc. | 36,187,519 | Mar 31, 2024 | 4.90% | 349,788,571 |
Morgan Stanley | 35,635,501 | Mar 31, 2024 | 4.82% | 344,452,765 |
FMR, LLC | 35,340,563 | Mar 31, 2024 | 4.78% | 341,601,894 |
Rubric Capital Management LP | 20,000,000 | Mar 31, 2024 | 2.71% | 193,320,007 |
State Street Corporation | 17,153,134 | Mar 31, 2024 | 2.32% | 165,802,199 |
Patient Square Capital LP | 12,228,465 | Mar 31, 2024 | 1.66% | 118,200,347 |
Woodline Partners LP | 11,172,306 | Mar 31, 2024 | 1.51% | 107,991,513 |
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 13,250,106 | Apr 30, 2024 | 1.79% | 128,075,529 |
iShares Core S&P Midcap ETF | 10,477,936 | Apr 30, 2024 | 1.42% | 101,279,733 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 6,666,669 | Apr 30, 2024 | 0.90% | 64,440,024 |
Vanguard Extended Market Index Fund | 5,085,818 | Mar 31, 2024 | 0.69% | 49,159,518 |
Fidelity Growth Company K6 Fund | 4,276,382 | Apr 30, 2024 | 0.58% | 41,335,509 |
Morgan Stanley Inst Fd Inc-Growth Port | 3,789,733 | Mar 31, 2024 | 0.51% | 36,631,560 |
Fidelity Series Growth Company Fund | 3,595,600 | Apr 30, 2024 | 0.49% | 34,755,070 |
Fidelity Select Portfolios - Biotechnology | 3,583,319 | Apr 30, 2024 | 0.49% | 34,636,362 |
iShares Biotechnology ETF | 3,570,108 | Apr 30, 2024 | 0.48% | 34,508,665 |
SPDR S&P Mid Cap 400 ETF Trust | 2,780,007 | May 31, 2024 | 0.38% | 26,871,548 |